IP Verse

Pharmaceutical Composition Containing Celecoxib And Tramadol - EP3323413

The patent EP3323413 was granted to YOO Young Pharm on Sep 2, 2020. The application was originally filed on Jun 29, 2016 under application number EP16824623A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3323413

YOO YOUNG PHARM
Application Number
EP16824623A
Filing Date
Jun 29, 2016
Status
Opposition Rejected
Mar 10, 2023
Grant Date
Sep 2, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBBJun 2, 2021PETERSADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTJP2014221797
INTERNATIONAL-SEARCH-REPORTKR20040067969
INTERNATIONAL-SEARCH-REPORTKR20080104910
INTERNATIONAL-SEARCH-REPORTKR20110122287
INTERNATIONAL-SEARCH-REPORTKR20130069484
OPPOSITIONKR20080104910
OPPOSITIONKR20130069484
OPPOSITIONKR20150099808
OPPOSITIONUS2009175939
OPPOSITIONWO2009049405
OPPOSITIONWO2011045075
OPPOSITIONWO2015016695
SEARCHUS2009175939
SEARCHWO2009049405
SEARCHWO2015016695

Non-Patent Literature (NPL) Citations (2) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX", CELEBREX, (20180601), pages 1 - 22, XP055951645-
OPPOSITION- Anonymous, "HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ULTRA ER ", ULTRAMER, (19950101), pages 1 - 37, XP055951647-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents